Publications by authors named "Magnus Ringbom"

Claim this Profile
F
First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies.
Åke Berglund, Anders Ullén, Alla Lisyanskaya, Sergey Orlov, Hans Hagberg, Magnus Ringbom

Invest New Drugs· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer.
Georg Holgersson, Stefan Bergström, Johan Harmenberg, Magnus Ringbom, Maria Klockare

Med Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis